HeartWare International Inc. (NASDAQ:HTWR) saw unusually-strong trading volume on Wednesday . Approximately 188,751 shares changed hands during mid-day trading, an increase of 8% from the previous session’s volume of 175,272 shares.The stock last traded at $57.97 and had previously closed at $57.96.

A number of research analysts have weighed in on HTWR shares. Canaccord Genuity restated a “buy” rating on shares of HeartWare International in a report on Saturday, April 30th. Bank of America Corp. restated a “buy” rating on shares of HeartWare International in a report on Monday, April 25th. BTIG Research restated a “buy” rating and issued a $45.00 price objective (down previously from $50.00) on shares of HeartWare International in a report on Tuesday, May 10th. Zacks Investment Research upgraded HeartWare International from a “hold” rating to a “buy” rating and set a $65.00 price objective on the stock in a report on Tuesday, August 2nd. Finally, Barclays PLC lowered HeartWare International from an “overweight” rating to an “equal weight” rating and raised their price objective for the company from $35.00 to $58.00 in a report on Wednesday, June 29th. Fourteen equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $53.57.

The firm’s 50-day moving average is $57.80 and its 200-day moving average is $38.81. The stock’s market capitalization is $1.02 billion.

HeartWare International (NASDAQ:HTWR) last issued its earnings results on Thursday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.82) by $0.39. The firm earned $68.72 million during the quarter, compared to analysts’ expectations of $57.36 million. The firm’s quarterly revenue was down 6.6% on a year-over-year basis. During the same period last year, the firm posted ($0.47) earnings per share. On average, analysts anticipate that HeartWare International Inc. will post ($3.09) earnings per share for the current year.

In other news, SVP James Schuermann sold 1,000 shares of HeartWare International stock in a transaction that occurred on Friday, July 1st. The shares were sold at an average price of $57.77, for a total value of $57,770.00. Following the completion of the sale, the senior vice president now directly owns 12,043 shares in the company, valued at $695,724.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Peter F. Mcaree sold 3,125 shares of HeartWare International stock in a transaction that occurred on Monday, July 11th. The stock was sold at an average price of $57.68, for a total transaction of $180,250.00. Following the completion of the sale, the chief financial officer now owns 22,130 shares of the company’s stock, valued at $1,276,458.40. The disclosure for this sale can be found here.

Heartware International, Inc is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.